ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 768

An Easy to Use Referral Model for Arthritis From the Rotterdam Early Arthitis Cohort

C. Alves1, Jolanda J. Luime1, Darian P. Shackleton2, P.J. Barendregt3, A.H. Gerards4 and Johanna M.W. Hazes1, 1Rheumatology, Erasmus University Medical Center, Rotterdam, Netherlands, 2Medisch Centrum Parklaan, Netherlands, 3Department of Rheumatology, Maasstad Hospital, Rotterdam, Netherlands, 4Department of Rheumatology, Vlietland Hospital, Schiedam, Netherlands

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Clinical practice guidelines, diagnostic criteria and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects I: Risk Factors and Prediction of Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

The first hurdle general practitioners (GPs) face to identify Rheumatoid Arthritis(RA) is to recognize presence of arthritis. Due to the low incidence of arthritis in primary care it is challenging  to differentiate between patients with inflammatory musculoskeletal disease and those without . We set out to create a referral model to aid early referral in primary care based on data from the REACH.

Methods:  

The REACH cohort includes patients with either arthritis or 2 painful joints with 2 additional inflammatory characteristics. Four hundred and one patients referred to REACH by their GPs were used in this analysis. A prediction model was build by selection of variables from the history, physical examination and laboratory values that were likely available to GPs. The presence of at least one joint with synovitis was used as outcome excluding patients with gout. Variable selection was performed  by classifying variables in 8 categories: symptoms, duration of complaints, life style, family history, comorbidity, medication use and systemic complaints (fever, skin disorder) followed by logistic regression with backward selection in each category. A referral model was build with the variables with p<0.1 evaluated in a logistic regression model that was bootstrapped 200 times to elicit the for optimism corrected c-statistic. Performance was also evaluated using ROC-curves and calibration plots. The addition of blood markers to the simple model was also evaluated.

Results:

Table 1 shows baseline characteristics for the 401 patients. Arthritis was present at baseline in 182 patients.  The referral model based on the REACH data resulted in a model containing the following variables: age, female sex, problems with fitting shoes, self-reported limitation of joint movement, lower number of self-reported painful joints, higher number of self-reported swollen joints, self-reported redness or hot/warm joints, the presence of squeeze pain in hand or feet and delay in presenting to the GP. The AUC was 0.79 (corrected for optimism: 0.72), adding ESR resulted in an AUC of 0.80 and adding RF resulted in 0.81. The simplest model calibrated slightly better (fig 1).

Conclusion:

We were able to create a referral model based on history taking and physical examination suitable for referral of patients with arthritis at risk for RA and perhaps other inflammatory diseases in primary care. Adding laboratory values did not improve performance and thus may be omitted based on the resources of the primary care facility.

Table 1. baseline characteristics

 

case, n=182

non case, n=219

 

 

age (mean, SD)

51 (15)

47 (12)

p<0.05

 

gender (%)

69%

66%

p<0.05

 

duration of complaints (median, range)

68 (4-370)

122 (1-416)

p<0.05

 

delay patient (median, range)

21 (0-328)

43 (0-361)

p<0.05

 

tender joint count (median, range)

7 (0-34)

6 (0-38)

ns

 

rheumatoid factor posistive (%)

25%

11%

p<0.05

 

anti-CCP positive (%)

17%

6%

p<0.05

*

ESR (median, range)

18(2-100)

8(0-66)

p<0.05

@

C-reactive proteine (median, range)

6 (1-180)

3 (1-55)

p<0.05

#

Diagnosis RA

0%

29%

p<0.05

$

* n=30 missing, @ n=63 missing, # n=92 missing, $ n=47 missing


Disclosure:

C. Alves,
None;

J. J. Luime,
None;

D. P. Shackleton,
None;

P. J. Barendregt,
None;

A. H. Gerards,
None;

J. M. W. Hazes,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/an-easy-to-use-referral-model-for-arthritis-from-the-rotterdam-early-arthitis-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology